Harmful mutations are permanent changes in DNA that disrupt normal protein function and, in many cases, lead to disease. They range from a single misplaced letter in a gene’s code, as in sickle cell disease, to entire chunks of chromosomes swapping places, as in certain leukemias. Some are inherited from a parent, some arise fresh during a person’s lifetime, and some accumulate quietly for years before they cause problems. The causes are just as varied, from ultraviolet light and toxic chemicals to simple copying errors your cells make every day.
How Mutations Happen in the First Place
Your cells copy their entire genome every time they divide, and that copying process is fast and mostly accurate, but not perfect. One common source of error is replication slippage: when the copying machinery encounters a stretch of repeated DNA letters, it can lose its place and skip ahead or loop back, inserting or deleting small segments. This slippage has been shown to involve the copying enzyme pausing within a repeated sequence and then falling off the DNA strand, leading to misalignment when it reattaches.1PubMed Central. Replication slippage involves DNA polymerase pausing and dissociation The result is that repetitive regions of the genome are especially prone to gaining or losing letters, which is why diseases linked to repeat expansions, like Huntington’s, tend to get worse across generations.
External agents called mutagens also damage DNA directly. Ultraviolet radiation from the sun is one of the most common. UV rays cause neighboring thymine bases in DNA to fuse together into structures called thymine dimers. If the cell fails to repair these fused bases before copying the DNA, the error gets permanently written into the genetic code.2PubMed. Detection of UV-Induced Thymine Dimers This is the core reason sunburn increases skin cancer risk: it is not just tissue damage, it is DNA damage.
Oxygen itself is another constant threat. Normal metabolism produces reactive oxygen species, which can chemically alter DNA bases. Cells have evolved an extensive toolkit of repair enzymes to fix this oxidative damage, but the repair system is not flawless, and some altered bases slip through.3PubMed Central. Oxidative DNA damage & repair: An introduction Chemical exposure adds yet another layer. Alkylating agents, found in certain industrial chemicals and even some chemotherapy drugs, attach chemical groups directly to DNA bases, creating lesions called adducts. These adducts can cause the DNA to be misread during copying, introducing mutations, or they can block copying entirely and kill the cell.4PubMed Central. Chemical biology of mutagenesis and DNA repair: cellular responses to DNA alkylation
Paternal Age and New Mutations
Not all harmful mutations are inherited from distant ancestors or caused by environmental toxins. Some arise brand-new in the sperm or egg cell that forms a child, and a well-documented risk factor is the father’s age. Sperm-producing cells keep dividing throughout a man’s life, and each division is another opportunity for a copying error. Research has confirmed that children born to older fathers have a higher frequency of new autosomal dominant mutations, reflecting the accumulation of copying errors in the male germ line over time.5PubMed Central. Paternal age effect in autosomal dominant or X-linked de novo variants identified by genome-wide sequencing This does not mean every older father will pass on a harmful mutation, but the statistical likelihood rises with each year, which is one reason genetic counselors sometimes flag paternal age alongside the more widely discussed maternal age.
Single-Letter Mutations That Cause Major Diseases
Some of the most dramatic examples of harmful mutations involve just a single base change in the DNA. Sickle cell disease is the textbook case: a single point mutation in codon six of the beta-globin gene swaps one amino acid for another in hemoglobin, causing red blood cells to deform into a crescent shape under low-oxygen conditions. The disease affects roughly 300,000 newborns each year worldwide.6PubMed Central. Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease Symptoms include episodes of severe pain, anemia, organ damage, and shortened life expectancy. The mutation is recessive, meaning you need two copies to develop the full disease.
Cystic fibrosis follows a similar pattern of inheritance but involves a different kind of mutation. The most common version, found in a large share of cystic fibrosis patients, is a deletion of three DNA letters that removes a single amino acid (phenylalanine at position 508) from the CFTR protein. That missing amino acid causes the protein to fold incorrectly, which impairs its ability to move chloride ions across cell membranes.7PubMed Central. CFTR: folding, misfolding and correcting the ΔF508 conformational defect The downstream effects are thick, sticky mucus in the lungs, pancreas, and other organs, leading to chronic infections and digestive problems.
Huntington’s disease illustrates a third pattern: not a substitution or a small deletion, but an expansion. The huntingtin gene contains a stretch of the sequence CAG repeated many times. In healthy people, the repeat is moderate in length. In people with Huntington’s, the repeat has expanded well beyond the normal range, producing an abnormally long protein that misfolds and aggregates in brain cells.8PubMed Central. RNA toxicity induced by expanded CAG repeats in Huntington’s disease Unlike sickle cell disease and cystic fibrosis, Huntington’s is dominant: a single copy of the expanded gene is enough to cause the disease, typically in middle age.
Mutations Outside the Nucleus
Most discussions of harmful mutations focus on nuclear DNA, the chromosomes you inherit from both parents. But you also carry a small, separate genome inside your mitochondria, the energy-producing structures in every cell. Mitochondrial DNA is inherited only from the mother, and mutations there can cause their own set of diseases. One well-studied example is MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes), which has been linked to specific point mutations in mitochondrial DNA.9PubMed Central. TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation
What makes mitochondrial mutations unusual is heteroplasmy: a single cell can contain a mix of normal and mutated mitochondrial DNA. The ratio matters enormously. If most of your mitochondrial copies carry the mutation, symptoms are severe. If only a small fraction carry it, you may have no symptoms at all. This is why mitochondrial diseases can vary wildly even within the same family, since the proportion of mutant mitochondria passed from mother to child is somewhat random.
When Whole Chromosomes Go Wrong
Not all harmful mutations are small-scale. Some involve large rearrangements or extra copies of entire chromosomes. Down syndrome is the most familiar example: it results from an extra copy of chromosome 21, usually caused by an error in how chromosomes separate during egg formation. Studies of families with Down syndrome have found that the error is strongly linked to maternal age and to altered patterns of genetic recombination during the egg cell’s development.10PubMed Central. Etiology of Down syndrome: Evidence for consistent association among altered meiotic recombination, nondisjunction, and maternal age across populations Having three copies of an entire chromosome throws off the dosage of hundreds of genes at once, which is why the effects are so wide-ranging, affecting heart development, cognitive ability, immune function, and more.
A different kind of chromosomal rearrangement drives chronic myeloid leukemia (CML). In this cancer, a piece of chromosome 9 breaks off and fuses with chromosome 22, creating a shortened chromosome 22 known as the Philadelphia chromosome. The fusion joins two genes, BCR and ABL, that are normally on separate chromosomes, producing a hybrid protein with uncontrolled enzyme activity that pushes white blood cells to multiply without stopping.11Cell. Molecular basis of the Philadelphia chromosome and the bcr-c-abl gene fusion This fusion is found in essentially all CML patients.12PubMed Central. BCR-ABL fusion genes and laboratory findings in patients with chronic myeloid leukemia in northeast Iran Experimental work confirmed that the fusion protein alone is enough to trigger leukemia-like disease in animal models.13Science. Induction of Chronic Myelogenous Leukemia in Mice by the P210 bcr/abl Gene of the Philadelphia Chromosome
The Philadelphia chromosome story has a rare happy ending in mutation biology. Because researchers pinpointed the exact fusion protein responsible, they developed a targeted drug (imatinib) that blocks its activity. CML went from being a near-certain death sentence to a highly manageable chronic condition for most patients within about a decade of the drug’s approval. It remains one of the clearest examples of understanding a mutation leading directly to an effective treatment.
Cancer Mutations and the p53 Problem
Cancer is, at its core, a disease of accumulated mutations. Most cancers are driven by somatic mutations, changes that arise in ordinary body cells during your lifetime rather than being inherited. But some people carry inherited mutations that dramatically raise their risk. Research has shown that in cancers diagnosed at younger ages, inherited variants in cancer-related genes play a larger role, while cancers in older people tend to be driven more by the somatic mutations that pile up over decades of life.14Nature Communications. Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden
One gene stands out above all others in the cancer landscape: TP53, which encodes the p53 protein. This protein acts as a quality-control checkpoint, stopping cells from dividing when their DNA is damaged and, when the damage is too severe, triggering the cell to destroy itself. Mutations that disable p53 remove that checkpoint. Over half of all human cancers carry mutations that knock out p53’s normal function.15PubMed Central. Role of p53 in Cell Death and Human Cancers Worse, some mutant versions of p53 don’t just lose their protective function; they actively promote tumor growth, a phenomenon called gain-of-function. Inheriting one broken copy of TP53 causes Li-Fraumeni syndrome, in which people develop multiple cancers, often starting in childhood.
What Happens When DNA Repair Itself Is Broken
Your cells sustain DNA damage constantly, from sunlight, from oxygen, from normal metabolism. What keeps most of us healthy is a set of repair systems that scan the genome, recognize damage, and fix it. When a mutation disables one of those repair systems, everyday damage becomes catastrophic.
Xeroderma pigmentosum (XP) is a striking illustration. People with XP carry mutations in the genes responsible for nucleotide excision repair, the system that removes UV-induced thymine dimers and other bulky DNA lesions. Without that system, sunlight damage accumulates unchecked, and XP patients develop extreme sensitivity to UV light and often develop multiple skin and eye cancers at very young ages.16PubMed Central. Nucleotide Excision Repair: From Molecular Defects to Neurological Abnormalities Many also develop neurological problems, and research has shown that the same repair pathway handles certain oxidative DNA lesions in the brain, suggesting that the neurodegeneration in XP is driven by unrepaired oxidative damage to neurons.17Proceedings of the National Academy of Sciences. In vitro repair of oxidative DNA damage by human nucleotide excision repair system: Possible explanation for neurodegeneration in Xeroderma pigmentosum patients Lab experiments confirmed that cell extracts from normal people can repair oxygen-radical damage that XP cell extracts cannot.18Proceedings of the National Academy of Sciences. DNA excision-repair defect of xeroderma pigmentosum prevents removal of a class of oxygen free radical-induced base lesions
XP makes visible what is normally invisible: the sheer volume of DNA damage your repair systems quietly handle every day. A person with functioning repair barely thinks about a day at the beach. A person without it risks skin cancer from a walk to the mailbox.
Why Some Harmful Mutations Persist in Populations
If sickle cell disease is so devastating, why hasn’t the mutation been eliminated by natural selection? The answer is one of the most elegant findings in human genetics. Carrying one copy of the sickle cell mutation (being a carrier without full disease) provides substantial protection against dying from malaria. This has been confirmed through clinical studies across multiple regions of sub-Saharan Africa.19PubMed Central. Sickle cell anaemia and malaria In areas where malaria is endemic, the survival advantage for carriers is large enough to maintain the mutation in the population even though people who inherit two copies develop severe disease. This trade-off, called balancing selection, explains why the sickle cell mutation is common in West Africa, parts of India, and the Mediterranean, all regions with historical malaria burden, but rare elsewhere.
Population size plays a role in how harmful mutations accumulate, too. Simulations and genetic analysis have shown that large populations actually harbor more hidden, strongly harmful recessive mutations than small ones. These mutations lurk undetected because carriers (who have only one copy) are healthy. But if the population suddenly shrinks, through habitat loss or a bottleneck event, inbreeding increases and those hidden mutations start pairing up. Populations that were historically large can actually go extinct faster after a bottleneck because they carry a heavier load of concealed harmful variants.20PubMed Central. Strongly deleterious mutations are a primary determinant of extinction risk due to inbreeding depression Conversely, populations that have been small for a long time tend to have already purged their most harmful recessive mutations through natural selection, as demonstrated in studies of island fox populations that persist without signs of inbreeding depression despite extremely low genetic diversity.21PubMed Central. Purging of Strongly Deleterious Mutations Explains Long-Term Persistence and Absence of Inbreeding Depression in Island Foxes
Cells Sometimes Work Around Mutations
One of the more surprising findings in recent genetics is that cells can sometimes dodge the effects of a mutation on their own. When researchers used gene-editing tools to introduce frameshift mutations (insertions or deletions that scramble the reading frame of a gene), they expected the gene to be completely knocked out. Instead, the cells sometimes skipped the damaged section entirely during the step where DNA is read into messenger RNA, stitching together a shorter but still partially functional protein.22PLoS ONE. Frameshift indels introduced by genome editing can lead to in-frame exon skipping This was observed in both human cells and zebrafish, and it means that some mutations that look devastating on paper may have milder effects in a living organism than you would predict. It also complicates gene-editing experiments, because what seems like a clean gene knockout may actually produce a truncated protein with residual activity.
This workaround does not apply to all mutations. It depends on the gene’s structure, specifically whether the damaged segment happens to correspond to a modular chunk that the cell’s splicing machinery can skip without throwing off the reading frame of the rest of the gene. Many harmful mutations are in regions where no such rescue is possible, which is why the mutations discussed earlier cause such serious disease.
Gene Editing as Treatment
Understanding exactly which mutation causes a disease opens the door to fixing it, at least in theory. CRISPR-Cas9 and related tools have moved from lab curiosity to clinical reality for a handful of genetic conditions. Sickle cell disease was one of the first targets, with the FDA approving a CRISPR-based therapy in late 2023. The approach involves editing a patient’s own blood stem cells outside the body and then returning them.
Newer refinements aim to make gene editing safer. Base editors, for example, can swap a single DNA letter without cutting both strands of the double helix, reducing the risk of unintended changes elsewhere in the genome.23PubMed Central. CRISPR–Cas9 Gene Editing: Curing Genetic Diseases by Inherited Epigenetic Modifications For diseases caused by a single known point mutation, like sickle cell disease or certain forms of beta-thalassemia, these tools are a particularly good fit because the target is precise and well characterized. For diseases involving larger rearrangements or multiple genes, the challenge remains far greater. And for mitochondrial diseases, standard CRISPR tools do not work well because they have difficulty entering mitochondria, though alternative approaches using engineered enzymes that can reach mitochondrial DNA are under active investigation.
Cost and accessibility remain significant barriers. Current gene therapies for sickle cell disease carry price tags in the millions of dollars per patient, and the procedure requires chemotherapy to clear out existing bone marrow before the edited cells are infused. The disease burden is highest in sub-Saharan Africa and South Asia, regions where that infrastructure is largely unavailable. For now, the most harmful mutations continue to exact the greatest toll in the populations least likely to access cutting-edge treatments.